For Breakthrough Innovation, Follow the Big Needs not the Existing Solutions
In healthcare, what really drives large-scale advances in patient care, access to therapies and economic value are approaches which are needs-based as opposed to technology-driven. Investing time and effort to understand those needs which have the greatest impact on clinical outcomes, economic value and customer satisfaction, and seeking out the best solutions regardless of their source is what truly moves the innovation needle – particularly in medical devices.
Mentorship Is Nice, But Sponsorship Changes the Game
What does it really take to turn the tides of diversity in the life sciences?
Some people say it’s about being more diligent in recruiting rather than relying on “tried and true” networks. Others say the secret is pairing young women and minorities with executive-level mentors who can lead by example.
JJDC and Janssen Immunology invest in BiomX, a pioneering microbiome therapeutics company
The microbiome represents a dramatically new frontier of medicine, with advances occurring in parallel across many modalities and disease areas. Underscoring the vast potential in this field, JJDC co-led an investment with Janssen Immunology and its IBD team in BiomX, Ltd., a pioneering microbiome therapeutics company.
Date or reference or blank 5 June 2017
Collaboration on Hyperdrive: Celebrating One Year of Successes at JLABS @ Toronto
This past year has been arguably the most exciting in history for Toronto’s life science community, with a new energy that’s percolating from the city’s core. There’s no question that Johnson & Johnson Innovation JLABS has been the catalyst for this.
It was just one seemingly short year ago that the first international JLABS location opened its doors right here in the scientific and medical heart of Toronto.